Gynecologic Cancer | Norton Healthcare

Indication: Gynecologic Cancer

GOG-0187: Phase II study of paclitaxel for Ovarian Stromal Tumors as first-line and second-line therapy.

Sub-indication: Gynecologic Cancer

Drug Study

Principal Investigator: Mary Gordinier, M.D.
Norton Cancer Institute

Sponsor: Gynecologic Oncology Group (GOG)

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.